Skip to main content
SpringerLink
Log in

Ophthalmika

  • Chapter
Arzneiverordnungs-Report 2012

  • 1324 Accesses

Zusammenfassung

Die Indikationsgruppe der Ophthalmika umfasst Präparate, die in aller Regel lokal angewendet werden. Abbildungen 36.1 und 36.2 geben als Übersichten die wichtigsten Arzneimittelgruppen des Gesamtmarktes wieder. In den letzten beiden Jahrzehnten ist es dabei zu beträchtlichen Verschiebungen gekommen. Während früher von den DDD fast zwei Drittel auf Glaukommittel, Antikataraktika und Sympathomimetika entfielen, dominierten bis 2003 neben den Glaukommitteln vor allem die Filmbildner (Abbildung 36.2).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Arzneimittelkommission der Deutschen Apotheker (2010): Rückruf Dexium 500 mg 100, 600 Kapseln Ch.-B.: alle Chargen. Pharm Ztg 155: 160.

    Google Scholar 

  • Behrens-Baumann W, Begall T (1993): Antiseptics versus antibiotics in the treatment of the experimental conjunctivitis caused by staphylococcus aureus. Ger J Ophthalmol 2: 409-411.

    PubMed  CAS  Google Scholar 

  • Bielory L (2002): Ocular allergy guidelines: a practical treatment algorithm. Drugs 62: 1611-1634.

    Article  PubMed  CAS  Google Scholar 

  • Bielory L, Lien KW, Bigelsen S (2005): Efficacy and tolerability of newer antihistamines in the treatment of allergic conjunctivitis. Drugs 65: 215-28.

    Article  PubMed  CAS  Google Scholar 

  • Biswas P, Sengupta S, Choudhary R, Home S, Paul A, Sinha S (2011) Comparative role of intravitreal ranibizumab versus bevacizumab in choroidal neovascular membrane in age-related macular degeneration. Indian J Ophthalmol. 59: 191-196.

    Article  PubMed  Google Scholar 

  • Chalita MR, Hofling-Lima AL, Paranhos A Jr, Schür P, Belfort R Jr (2004): Shifting trends in in vitro antibiotic susceptibilities for common ocular isolates during a period of 15 years. Am J Ophthalmol 137: 43-51.

    Article  PubMed  Google Scholar 

  • Costagliola C, dell'Omo R, Romano MR, Rinaldi M, Zeppa L, Parmeggiani F (2009a): Pharmacotherapy of intraocular pressure: part I. Parasympathomimetic, sympathomi- metic and sympatholytics. Expert Opin Pharmacother. 10: 2663-2677.

    Article  CAS  Google Scholar 

  • Costagliola C, dell'Omo R, Romano MR, Rinaldi M, Zeppa L, Parmeggiani F (2009b): Pharmacotherapy of intraocular pressure - part II. Carbonic anhydrase inhibitors, prostaglandin analogues and prostamides. Expert Opin Pharmacother. 10: 2859-2870.

    Article  CAS  Google Scholar 

  • Cvetkovic RS, Perry CM (2003): Brinzolamide: a review of its use in the management of primary open-angle glaucoma and ocular hypertension. Drugs Aging 20: 919-947.

    Article  PubMed  CAS  Google Scholar 

  • Danesh-Meyer HV (2011): Neuroprotection in glaucoma: recent and future directions. Curr Opin Ophthalmol 22: 78-86

    Article  PubMed  Google Scholar 

  • Dietlein TS, Hermann MM, Jordan JF (2009): Medikamentöse und chirurgische Therapie des Glaukoms. Dtsch Ärztebl Int 106: 597-606.

    PubMed  Google Scholar 

  • European Glaucoma Society: Terminologie und Handlungsrichtlinien für die Glaukome. 3.rd ed. (2008), DOGMA, Savona, Italien (www.eugs.org/eng/EGS_guidelines.asp).

  • Everett SL, Kowalski RP, Karenchak LM, Landsittel D, Day R, Gordon YL (1995): An in vitro comparison of the susceptibilities of bacterial isolates from patients with conjunc- tivitis and blepharitis to newer and established topical antibiotics. Cornea 14: 382-387.

    Article  PubMed  CAS  Google Scholar 

  • Everitt HA, Little PS, Smith PW (2006): A randomised controlled trial of management strategies for acute infective conjunctivitis in general practice. Brit med J 333: 321.

    Article  Google Scholar 

  • Feiner L, Piltz-Seymour JR; Collaborative Initial Glaucoma Treatment Study (2003): Collaborative Initial Glaucoma Treatment Study: a summary of results to date. Curr Opin Ophthalmol 14: 106-111.

    Article  PubMed  Google Scholar 

  • Gharbiya M, Giustolisi R, Allievi F, Fantozzi N, Mazzeo L, Scavella V, Gabrieli CB (2010): Choroidal neovascularization in pathologic myopia: intravitreal ranibizumab versus bevacizumab - a randomized controlled trial. Am J Ophthalmol 149: 458-64.e1.

    Article  PubMed  CAS  Google Scholar 

  • Giardini F, Grandi G, De Sanctis U, Eandi C, Machetta F, Pollino C, Grignolo FM (2011) In vitro susceptibility to different topical ophthalmic antibiotics of bacterial isolates from patients with conjunctivitis. Ocul Immunol Inflamm. 19: 419-421.

    Article  PubMed  CAS  Google Scholar 

  • Göbbels M, Gross D (1996): Klinische Studie der Wirksamkeit einer Dexpanthenol- haltigen künstlichen Tränenflüssigkeit (Siccaprotect) bei der Behandlung des trockenen Auges. Klin Monatsbl Augenheilkd 209: 84-88.

    Article  PubMed  Google Scholar 

  • Goldberg I (2002): Should beta blockers be abandoned as initial monotherapy in chronic open angle glaucoma? The controversy. Br J Ophthalmol 86: 691-692.

    Article  PubMed  CAS  Google Scholar 

  • Goldberg I, Crowston JG, Jasek MC, Stewart JA, Stewart WC; ADAPT Study Investigator Group (2012): Intraocular pressure-lowering efficacy of brinzolamide when added to travoprost/timolol fixed combination as adjunctive therapy. J Glaucoma 21: 55-59.

    Article  PubMed  Google Scholar 

  • Granet DB, Dorfman M, Stroman D, Cockrum P (2008): A multicenter comparison of polymyxin B sulfate/trimethoprim ophthalmic solution and moxifloxacin in the speed of clinical efficacy for the treatment of bacterial conjunctivitis. J Pediatr Ophthalmol Strabismus 45: 340-349.

    Article  PubMed  Google Scholar 

  • Grehn F (2008): Chirurgie des primären Offenwinkelglaukoms. Klin Monatsbl Augenheilkd 225: 30-38.

    Article  PubMed  CAS  Google Scholar 

  • Greiner JV, Michaelson C, McWhirter CL, Shams NB (2002): Single dose of ketotifen fumarate .025% vs 2 weeks of cromolyn sodium 4% for allergic conjunctivitis. Adv Ther 19: 185-193.

    Article  PubMed  CAS  Google Scholar 

  • Grieshaber MC, Flammer J (2010): Is the medication used to achieve the target intraocu- lar pressure in glaucoma therapy of relevance? - an exemplary analysis on the basis of two beta-blockers. Prog Retin Eye Res. 29: 79-93.

    Article  PubMed  CAS  Google Scholar 

  • Gunther JB, Altaweel MM (2009): Bevacizumab (avastin) for the treatment of ocular disease. Surv Ophthalmol 54: 372-400.

    Article  PubMed  Google Scholar 

  • Haas W, Hesje CK, Sanfilippo CM, Morris TW (2011): High proportion of nontypeable Streptococcus pneumoniae isolates among sporadic, nonoutbreak cases of bacterial conjunctivitis. Curr Eye Res 36: 1078-1085.

    Article  PubMed  CAS  Google Scholar 

  • Hanioglu-Kargi S, Basci N, Soysal H, Bozkurt A, Gursel E, Kayaalp O (1998): The penetration of ofloxacin into human aqueous humor given by various routes. Eur J Ophthalmol 8: 33-36.

    PubMed  CAS  Google Scholar 

  • Herkel U, Pfeiffer N (2001): Update on topical carbonic anhydrase inhibitors. Curr Opin Ophthalmol 12: 88-93.

    Article  PubMed  CAS  Google Scholar 

  • Hodge WG, Lachaine J, Steffensen I, Murray C, Barnes D, Foerster V, Ducruet T, Morrison A (2008): The efficacy and harm of prostaglandin analogues for IOP reduction in glaucoma patients compared to dorzolamide and brimonidine: a systematic review. Br J Ophthalmol 92: 7-12.

    Article  PubMed  CAS  Google Scholar 

  • Holz F, Martini B (2007): Pegaptanib. Intravitreale Injektion bei neovaskulärer altersabhängiger Makuladegeneration. Arzneimitteltherapie 25: 47-50.

    CAS  Google Scholar 

  • Hwang DG, Schanzlin DJ, Rotberg MH, Foulks G, Raizman MB; Levofloxacin Bacterial Conjunctivitis Place-controlled Study Group (2003): A phase III, placebo controlled clinical trial of 0.5% levofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis. Br J Ophthalmol. 87: 1004-1009.

    Article  PubMed  CAS  Google Scholar 

  • Isenberg SJ, Apt L, Valenton M, Del Signore M, Cubillan L, Labrador MA et al (2002): A controlled trial of povidone-iodine to treat infectious conjunctivitis in children. Am J Ophthalmol 134: 681-688.

    Article  PubMed  CAS  Google Scholar 

  • Jackson WB, Low DE, Dattani D, Whitsitt PF, Leeder RG, MacDougall R (2002): Treatment of acute bacterial conjunctivitis: 1% fusidic acid viscous drops vs. 0.3% tobramycin drops. Can J Ophthalmol 37: 228-237.

    PubMed  Google Scholar 

  • Kass MA, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP et al (2002): The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 120: 701-713.

    Article  PubMed  Google Scholar 

  • Kass MA, Gordon MO, Gao F, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JK, Miller JP, Parrish RK, Wilson MR; Ocular Hypertension Treatment Study Group (2010): Delaying treatment of ocular hypertension: the ocular hypertension treatment study. Arch Ophthalmol. 128: 276-287.

    Article  PubMed  Google Scholar 

  • Katz LJ (1999): Brimonidine tartrate 0.2% twice daily vs timolol 0.5% twice daily: 1-year results in glaucoma patients. Brimonidine Study Group. Am J Ophthalmol 127: 20-26.

    Article  PubMed  CAS  Google Scholar 

  • Kidd M, McKenzie SH, Steven I, Cooper C, Lanz R; Australian Ketotifen Study Group (2003): Efficacy and safety of ketotifen eye drops in the treatment of seasonal allergic conjunctivitis. Br J Ophthalmol 87: 1206-1211.

    Article  PubMed  CAS  Google Scholar 

  • Koss MJ, Eder M, Blumenkranz MS, Klauss V, Ta CN, de Kaspar HM (2007): Wirksamkeit neuer Fluorchinolone gegenüber der bakteriellen Normalflora der Bindehaut. Ophthalmologe 104: 21-27

    Article  PubMed  CAS  Google Scholar 

  • Krupin T, Liebmann JM, Greenfield DS, Ritch R, Gardiner S; Low-Pressure Glaucoma Study Group (2011): A randomized trial of brimonidine versus timolol in preser- ving visual function: results from the Low-Pressure Glaucoma Treatment Study. Am J Ophthalmol 151: 671-681.

    Article  PubMed  CAS  Google Scholar 

  • Lai DS, Lue KH, Hsieh JC, Lin KL, Lee HS (2002): The comparison of the efficacy and safety of cetirizine, oxatomide, ketotifen, and a placebo for the treatment of childhood perennial allergic rhinitis. Ann Allergy Asthma Immunol 89: 589-598.

    Article  PubMed  CAS  Google Scholar 

  • Lynch SS, Cheng CM (2007): Bevacizumab for neovascular ocular diseases. Ann Pharmacother. 41: 614-625.

    Article  PubMed  CAS  Google Scholar 

  • Mantadakis E, Maraki S, Michailidis L, Gitti Z, Pallikaris IG, Samonis G (2012): Antimicrobial susceptibility of Gram-positive cocci isolated from patients with con- junctivitis and keratitis in Crete, Greece. J Microbiol Immunol Infect. Im Druck. PMID: 22209987.

    Google Scholar 

  • Martin DF, Maguire MG, Fine SL, Ying GS, Jaffe GJ, Grunwald JE, Toth C, Redford M, Ferris FL 3rd; Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group Writing Committee (2012): Ranibizumab and Bevacizumab for Treatment of Neovascular Age-Related Macular Degeneration: Two-Year Results. Ophthalmology. Im Druck [Epub ahead of print] PMID: 22555112.

    Google Scholar 

  • Messmer EM (2012): Bakterielle Konjunktivitis - Update zu Diagnose und Therapie. Klin Monbl Augenheilkd. 229: 529-533.

    Article  PubMed  CAS  Google Scholar 

  • Musch DC, Gillespie BW, Niziol LM, Lichter PR, Varma R; CIGTS Study Group (2011): Intraocular pressure control and long-term visual field loss in the Collaborative Initial Glaucoma Treatment Study. Ophthalmology. 118: 1766-1773.

    Article  PubMed  Google Scholar 

  • Noble S, McTavish D (1995): Levocabastine. An update of its pharmacology, clinical ef- ficacy and tolerability in the topical treatment of allergic rhinitis and conjunctivitis. Drugs 50: 1032-1049.

    Article  PubMed  CAS  Google Scholar 

  • Nordlund JR, Pasquale LR, Robin AL et al (1995): The cardiovascular, pulmonary, and ocular hypotensive effects of 0.2% brimonidine. Arch Ophthalmol 113: 77-83.

    Article  PubMed  CAS  Google Scholar 

  • O'Brien TP, Maguire MG, Fink NE, Alfonso E, McDonnell P (1995): Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis. Arch Ophthalmol 113: 1257-1265.

    Article  PubMed  Google Scholar 

  • Orden Martinez B, Martinez Ruiz R, Millan Perez R (2004): Bakterielle Konjunktivitis: Prävalenz von Pathogenen und ihre Antibiotikaresistenz [Artikel auf Spanisch]. An Pediatr (Barc) 61: 32-36.

    Article  CAS  Google Scholar 

  • Parrish RK, Palmberg P, Sheu WP and the XLT Study Group (2003): A comparison of la- tanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study. Am J Ophthalmol 135: 688-703.

    Article  PubMed  CAS  Google Scholar 

  • Parrish RK, Feuer WJ, Schiffman JC, Lichter PR, Musch DC; CIGTS Optic Disc Study Group (2009): Five-year follow-up optic disc findings of the Collaborative Initial Glaucoma Treatment Study. Am J Ophthalmol 147: 717-724.

    Article  PubMed  Google Scholar 

  • Perry CM, McGavin JK, Culy CR, Ibbotson T (2003): Latanoprost: an update of its use in glaucoma and ocular hypertension. Drugs Aging 20: 597-630.

    Article  PubMed  CAS  Google Scholar 

  • Pfeiffer N (2005): Ergebnisse der „Ocular hypertension treatment study" (OHTS) Ophthalmologe 102: 230-234.

    Article  PubMed  CAS  Google Scholar 

  • Pfeiffer N, TATS (Travatan Adjunctive Treatment Study) group (2011) Timolol versus brinzolamide added to travoprost in glaucoma or ocular hypertension. Graefes Arch Clin Exp Ophthalmol. 249: 1065-1071.

    Article  PubMed  CAS  Google Scholar 

  • Quigley HA (1996): Number of people with glaucoma worldwide. Brit J Ophthalmol 80: 389-393.

    Article  CAS  Google Scholar 

  • Ravinet E, Mermoud A, Brignoli R (2003): Four years later: a clinical update on latanoprost. Eur J Ophthalmol 13: 162-175.

    PubMed  CAS  Google Scholar 

  • Rietveld RP, ter Riet G, Bindels PJ, Sloos JH, van Weert HC (2004): Predicting bacterial cause in infectious conjunctivitis: cohort study on informativeness of combinations of signs and symptoms. Brit med J 329: 206-210.

    Article  Google Scholar 

  • Robert PY, Adenis JP (2001): Comparative review of topical ophthalmic antibacterial pre- parations. Drugs 61: 175-185.

    Article  PubMed  CAS  Google Scholar 

  • Rose P (2007): Management strategies for acute infective conjunctivitis in primary care: a systematic review. Expert Opin Pharmacother 8: 1903-1921.

    Article  PubMed  CAS  Google Scholar 

  • Rosenfeld PJ (2011): Bevacizumab versus Ranibizumab - The Verdict. New Engl J Med,. 364: 1966-1967.

    Article  PubMed  CAS  Google Scholar 

  • Schachar RA, Raber S, Courtney R, Zhang M (2011): A phase 2, randomized, dose-res- ponse trial of taprenepag isopropyl (PF-04217329) versus latanoprost 0.005% in open- angle glaucoma and ocular hypertension. Curr Eye Res. 36: 809-817.

    Article  PubMed  CAS  Google Scholar 

  • Schalnus R (2003): Topical nonsteroidal anti-inflammatory therapy in ophthalmology. Ophthalmologica 217: 89-98.

    Article  PubMed  CAS  Google Scholar 

  • Schwab IR, Friedlaender M, McCulley J, Lichtenstein SJ, Moran CT; Levofloxacin Bacterial Conjunctivitis Active Control Study Group (2003): A phase III clinical trial of 0.5% levofloxacin ophthalmic solution versus 0.3% ofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis. Ophthalmology 110: 457-465.

    Article  PubMed  Google Scholar 

  • Sena DF, Ramchand K, Lindsley K (2010): Neuroprotection for treatment of glaucoma in adults. Cochrane Database Syst Rev. 2010: CD006539.

    Google Scholar 

  • Sheikh A, Hurwitz B, Cave J (2000): Antibiotics versus placebo for acute bacterial conjunctivitis. Cochrane Database Syst Rev 2000: CD001211.

    Google Scholar 

  • Shiuey Y, Ambati BK, Adamis AP (2000): A randomized, double-masked trial of topical ketorolac versus artificial tears for treatment of viral conjunctivitis. Ophthalmology 107: 1512-1517.

    Article  PubMed  CAS  Google Scholar 

  • Sorensen SJ, Abel SR (1996): Comparison of the ocular beta-blockers. Ann Pharmacother 30: 43-54.

    PubMed  CAS  Google Scholar 

  • Srinivasan M, Lalitha P, Mahalakshmi R, Prajna NV, Mascarenhas J, Chidambaram JD, Lee S, Hong KC, Zegans M, Glidden DV, McLeod S, Whitcher JP, Lietman TM, Acharya NR (2009): Corticosteroids for bacterial corneal ulcers. Br J Ophthalmol 93: 198-202.

    Article  PubMed  CAS  Google Scholar 

  • Subramanian ML, Ness S, Abedi G, Ahmed E, Daly M, Feinberg E, Bhatia S, Patel P, Nguyen M, Houranieh A (2009) Bevacizumab vs ranibizumab for age-related macular degeneration: early results of a prospective double-masked, randomized clinical trial. Am J Ophthalmol 148: 875-882.e1.

    Article  PubMed  CAS  Google Scholar 

  • Szaflik J, Szaflik JP, Kaminska A; Levofloxacin Bacterial Conjunctivitis Dosage Study Group (2009): Clinical and microbiological efficacy of levofloxacin administered three times a day for the treatment of bacterial conjunctivitis. Eur J Ophthalmol 19: 1-9.

    PubMed  CAS  Google Scholar 

  • The AGIS Investigators (2000): The advanced glaucoma intervention study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol 130: 429-440.

    Article  Google Scholar 

  • The CATT Research Group (2011): Ranibizumab and bevacizumab for neovascular age- related macular degeneration. New Engl J Med, 364: 1897-1908.

    Article  Google Scholar 

  • The IVAN Study Investigators Writing Committee: Chakravarthy U, Harding SP, Rogers CA, Downes SM, Lotery AJ, Wordsworth S, Reeves BC (2012) Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trial. Ophthalmology. Im Druck. PMID: 22578446.

    Google Scholar 

  • Uusitalo H, Pillunat LE, Ropo A (2010): Efficacy and safety of tafluprost 0.0015% versus latanoprost 0.005% eye drops in open angle glaucoma and ocular hypertension: 24-month results of a randomized, double-masked phase III study. Acta Ophthalmol. 88: 12-19.

    Article  PubMed  CAS  Google Scholar 

  • Wand M, Gilbert CM, Liesegang TJ (1999): Latanoprost and herpes simplex keratitis. Am J Ophthalmol 127: 602-604.

    Article  PubMed  CAS  Google Scholar 

  • Watson PG, Barnett MF, Parker V, Haybittle J (2001): A 7 year prospective comparative study of three topical beta blockers in the management of primary open angle glauco- ma. Br J Ophthalmol 85: 962-968.

    Article  PubMed  CAS  Google Scholar 

  • Webers CA, Beckers HJ, Nuijts RM, Schouten JS (2008): Pharmacological management of primary open-angle glaucoma: second-line options and beyond. Drugs Aging 25: 729-759.

    Article  PubMed  CAS  Google Scholar 

  • Weinreb RN, Khaw PT (2004): Primary open-angle glaucoma. Lancet 363: 1711-1720.

    Article  PubMed  Google Scholar 

  • Whitson JT (2007): Glaucoma: a review of adjunctive therapy and new management stra- tegies. Expert Opin Pharmacother 8: 3237-3249.

    Article  PubMed  CAS  Google Scholar 

  • Williams RD, Novack GD, van Haarlem T, Kopczynski C; AR-12286 Phase 2A Study Group (2011): Ocular hypotensive effect of the Rho kinase inhibitor AR-12286 in pati- ents with glaucoma and ocular hypertension. Am J Ophthalmol. 152: 834-841.

    Article  PubMed  CAS  Google Scholar 

  • Wright M, Butt Z, McIlwaine G, Fleck B (1997): Comparison of the efficacy of diclofenac and betamethasone following strabismus surgery. Brit J Ophthalmol 81: 299-301.

    Article  CAS  Google Scholar 

  • Yildirim N, Sahin A, Gultekin S (2008): The effect of latanoprost, bimatoprost, and travo- prost on circadian variation of intraocular pressure in patients with open-angle glau- coma. J Glaucoma 17: 36-39.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institut für Pharmakologie und Toxikologie, Universität Würzburg, Versbacher Straße 9, 97078, Würzburg

    Prof. Dr. med. Martin J. Lohse

Authors
  1. Prof. Dr. med. Martin J. Lohse
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Medizin Verlag Berlin, Heidelberg

About this chapter

Cite this chapter

Lohse, M. (2012). Ophthalmika. In: Arzneiverordnungs-Report 2012. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-29242-2_36

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-29242-2_36

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-29241-5

  • Online ISBN: 978-3-642-29242-2

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation